Ikarian Capital »

Veru shares owned by Ikarian Capital

Quarter-by-quarter ownership of Veru shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Veru

Tip: Access up to 7 years of quarterly data

All positions including Veru held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veru by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $542k 143k 3.80

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Veru

Vanguard Group
Millennium Management
Oppenheimer & Co
Summit Financial
GSA Capital Partners
Sheets Smith Investment Management
Geode Capital Management
Ikarian Capital
Susquehanna International
BlackRock
UBS Group
Adage Capital Partners GP
Citadel Advisors
Envestnet Asset Management
Rsm Us Wealth Management

View all funds holding Veru